

Developer of drug discovery platform for the treatments of chronic viral infections. The company develops molecules modulating host functions for the treatment of acute and chronic viral infections and identify new intracellular therapeutic targets and molecules acting against these targets. Among its major competitors, ENYO Pharma is ranked in 5th place for NPS while Biogen is 1st, and Athersys is 2nd.